Dr. Mohammed Eyad Yaseen Alsabbagh, MD

Dr. Alsabbagh practices at Mercy Hospital South in Saint Louis, Missouri, part of Mercy.

Dr. Alsabbagh's NPI, 1083917090, was assigned on December 13, 2010. Dr. Alsabbagh holds Missouri license 2017006373.

Dr. Alsabbagh's primary practice is Mercy Hospital South, at 10010 Kennerly Road, Saint Louis, MO 63128 in St. Louis County. The practice phone is (314) 525-1000.

Dr. Alsabbagh's primary practice is Mercy Hospital South in Saint Louis, Missouri, part of Mercy. Dr. Alsabbagh is also affiliated with Mercy Hospital St. Louis. The medical group on file is Mercy Clinic Gastroenterology. Dmand AI also links Dr. Alsabbagh to 2 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alsabbagh practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Alsabbagh's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Alsabbagh is licensed in Missouri.

CMS data shows 347 Medicare services from Dr. Alsabbagh across 11 procedure codes in 2024, for 226 Medicare patients. Medicare paid $37,228 for them.

CMS counts 226 Medicare patients who saw Dr. Alsabbagh in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alsabbagh's median patient age at 67, with 53% women.

In 2024, Dr. Alsabbagh wrote 732 Medicare Part D claims for 385 patients. 83% of them were for generic drugs. CMS names the drug for 537 of them, across 9 drugs with 11 or more claims each, at $25,479 in total drug cost. In 2023, CMS named 267 claims across 11 drugs.

Dr. Alsabbagh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alsabbagh as offering telehealth. CMS counts 98 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Alsabbagh, more than 76% of the clinicians it reports for that procedure.

CMS Open Payments shows 147 general payments to Dr. Alsabbagh from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Gilead Sciences, Inc. paid the most, $50,428. It also lists 1 research payment totaling $78 in 2019.